Report title: Denmark pharma: Novo Nordisk wins Europe OK for diabetes drug
from EIU Country Analysis
84 word report published Jul 03, 2009

Price $34.00 available for immediate download
Report Overview
 
Search Inside
 
About EIU Country Analysis

FROM DIALOG NEWSEDGE [MarketWatch Bullets] Novo Nordisk nvo said the European Commission has granted marketing authorisation for Victoza, or liraglutide, for the treatment of type # diabetes in adults. Novo Nordisk will launch Victoza...

Source: Healthcare Industry Briefing
Geography / Regions: Denmark
Industry: Healthcare, Pharma & biotech
Free Sample: Click Here to Download
Format:
HTML HTML


Enter the keyword(s) which you would like to search for within this document and click "Search"  


Price: $34.00



  Can't Decide?

Purchasing premium research sight unseen can be intimidating. At Alacra we want you to know what you are getting. Visit our FAQ or ask our Customer Service Team any questions about the report you are considering purchasing.